Landscape Capital Management L.L.C. bought a new stake in Enhabit, Inc. (NYSE:EHAB – Get Rating) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 15,667 shares of the company's stock, valued at approximately $220,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. DekaBank Deutsche Girozentrale acquired a new stake in Enhabit in the third quarter valued at $177,000. Los Angeles Capital Management LLC bought a new stake in shares of Enhabit in the 3rd quarter worth about $1,460,000. Victory Capital Management Inc. acquired a new stake in shares of Enhabit in the 3rd quarter valued at about $9,221,000. Oregon Public Employees Retirement Fund bought a new position in shares of Enhabit during the third quarter worth about $230,000. Finally, Brinker Capital Investments LLC bought a new position in shares of Enhabit during the third quarter worth about $692,000. 95.55% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

EHAB has been the topic of several research reports. Credit Suisse Group cut their price objective on Enhabit from $19.00 to $15.00 and set a "neutral" rating on the stock in a research note on Friday, November 4th. UBS Group started coverage on Enhabit in a research note on Thursday, December 8th. They set a "sell" rating and a $12.00 price objective on the stock. Oppenheimer assumed coverage on shares of Enhabit in a research note on Thursday, October 13th. They set a "market perform" rating for the company. Stifel Nicolaus assumed coverage on shares of Enhabit in a report on Monday, December 5th. They set a "buy" rating and a $17.00 target price on the stock. Finally, CJS Securities assumed coverage on shares of Enhabit in a report on Tuesday, December 13th. They issued a "market perform" rating and a $18.00 price target for the company. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $16.43.

Enhabit Trading Up 2.5 %

Enhabit (NYSE:EHAB – Get Rating) last posted its earnings results on Tuesday, November 1st. The company reported $0.19 EPS for the quarter, missing the consensus estimate of $0.28 by ($0.09). The firm had revenue of $265.70 million during the quarter, compared to the consensus estimate of $265.62 million. Enhabit had a return on equity of 7.62% and a net margin of 7.76%. On average, sell-side analysts forecast that Enhabit, Inc. will post 1.45 EPS for the current year.

Insider Activity at Enhabit

In other Enhabit news, Director Jeffrey Bolton bought 2,000 shares of the business's stock in a transaction on Wednesday, November 9th. The shares were purchased at an average price of $12.75 per share, with a total value of $25,500.00. Following the purchase, the director now directly owns 14,597 shares of the company's stock, valued at $186,111.75. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, Director Gregory S. Rush purchased 8,300 shares of Enhabit stock in a transaction dated Monday, November 7th. The stock was bought at an average cost of $12.69 per share, with a total value of $105,327.00. Following the purchase, the director now owns 16,597 shares in the company, valued at approximately $210,615.93. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, Director Jeffrey Bolton acquired 2,000 shares of the firm's stock in a transaction dated Wednesday, November 9th. The stock was bought at an average price of $12.75 per share, with a total value of $25,500.00. Following the completion of the acquisition, the director now directly owns 14,597 shares of the company's stock, valued at $186,111.75. The disclosure for this purchase can be found here. Insiders have acquired a total of 13,000 shares of company stock worth $164,903 in the last three months.

About Enhabit

(Get Rating)

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.

Featured Articles

• Get a free copy of the StockNews.com research report on Enhabit (EHAB)
• Is Canadian Solar Too Hot to Handle?
• UiPath is the Blue-Collar AI Platform to Watch in 2023
• CVS Health is Growing into an Integrated Healthcare Organization
• Is C3.ai Stock a ChatGPT Artificial Intelligence Play?
• NVIDIA Outlook Improving: Watchlist Candidate for 2023

Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.